M. James Barrett, 10% Owner at Adaptimmune Therapeutics PLC (ADAP), bought 12,870,000 shares at $0.70 ($9.0M) on 2017-03-27, disclosed to the SEC on 2017-03-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| GLYC | SELL | 2018-05-11 | $340K | — | Filing → |
| SURF | BUY | 2018-04-23 | $2.0M | — | Filing → |
| ADAP | BUY | 2018-03-28 | $13.7M | — | Filing → |